HLS is a pharmaceutical company focused on the acquisition and commercialization of late-stage development or commercial-stage products in the United States and Canadian markets. HLS's current products focus on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. HLS's management team is composed of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.
Learn More